Panbela Therapeutics, Inc. Convertible Notes Payable, Noncurrent
Panbela Therapeutics, Inc. had Convertible Notes Payable, Noncurrent of $1.10 million as of 2017-09-30, per its 10-Q filed 2017-11-14.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Excluding Current Maturities
us-gaap:ConvertibleLongTermNotesPayable · last filed 2017-11-14
- 2017-09-30: Convertible Notes Payable, Noncurrent $1.10M.
- 2017-06-30: Convertible Notes Payable, Noncurrent $667.00K.
- 2017-03-31: Convertible Notes Payable, Noncurrent $237.00K.
- 2016-09-30: Convertible Notes Payable, Noncurrent $2.73M.
| Period end | Convertible Notes Payable, Noncurrent | Convertible Notes Payable, Noncurrent as first filed |
|---|---|---|
| 2017-09-30 | $1.10M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $667.00K 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $237.00K 10-Q · filed 2017-05-11 | |
| 2016-09-30 | $2.73M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $2.72M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $2.72M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $2.71M 10-K · filed 2017-03-30 | $2.77M 10-K · filed 2016-03-08 |
| 2015-09-30 | $2.77M 10-Q · filed 2015-11-16 | |
| 2014-12-31 | $3.00M 10-K · filed 2016-03-08 |